Search 33,000+ CME courses
Back

StatPearls, LLC

  • Adenoma, Liver Cell
  • Anabolic Androgenic Steroids
  • Contraceptives, Oral
  • Fanconi Anemia
  • Rupture

Hepatocellular Adenoma

Hepatocellular adenoma, also called “hepatic adenoma,” is a rare, benign epithelial liver tumor frequently associated with oral contraceptive pill intake. Conditions like anabolic steroid abuse, Fanconi anemia, and aplastic anemia have also been implicated in the development of this lesion. Hepatic adenomas are benign but carry a higher hemorrhage and malignant transformation risk. Elective resection is recommended in all men with adenomas of any size and women with tumors larger than 5 cm. Rupture may complicate untreated lesions, manifesting with hemorrhage, severe abdominal pain, and hypotension, and may lead to hypovolemic shock and death. Women on oral contraceptives are most susceptible to liver adenoma rupture, which requires immediate recognition due to its potentially catastrophic consequences. This activity for healthcare professionals is designed to improve learners’ competence in evaluating and managing hepatocellular adenoma. Participants gain profound insights into the condition’s pathophysiology, symptomatology, and evidence-based diagnostic and treatment practices. Learners become prepared to collaborate within an interprofessional team caring for patients with or at risk for hepatic adenoma.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 9 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

Related courses

See all

Other providers’ courses on the same topic

More from StatPearls, LLC

See all

This provider’s courses closest to this one